Peel Hunt eyes progress after wider full-year loss 09:02 , Graeme Evans Investment bank Peel Hunt ...

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

Nagpur: A blood donation and health check-up camp was organised on Saturday at the MIDC Industries Association (MIA) premises ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

A host of Cambridgeshire people - from charity leaders to academics - have been honoured in His Majesty The King’s Birthday ...

England’s NHS has launched a groundbreaking “Trojan Horse” therapy for the treatment of myeloma, offering hope for thousands ...

India also impacted by Shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five ...

Bengaluru: In a BSE filing, Syngene International has informed that the company's facility at Semicon Park, Bengaluru has ...

EMA accepts for regulatory review GSK’s RSV vaccine, Arexvy to expand use in adults 18 years and older: London, UK Saturday, June 14, 2025, 10:00 Hrs [IST] GSK plc announced tha ...

With over 70 per cent of its medicines imported and porous borders that are difficult to police, Nigeria has become a fertile ...

The Victorian scientists who spotted the perplexing new signal say their data still shows strong protection from the jab.